Provocative Questions in Cancer Research: National Cancer Institute Science Writers’ Seminar
- Posted: November 27, 2012
- Updated: December 12, 2012
What: The NCI science writers' seminar discussed various aspects of one of NCI’s signature efforts -- the Provocative Questions project. Discussion focused on the scientific research that surrounds some of these questions. The seminar allowed ample time for Q&A and interaction during the talks.
Who: Experts from NCI included:
The Provocative Questions Program: An overview
Ed Harlow, Ph.D., special advisor to the NCI Director
How can drugs, such as aspirin or metformin, which are used for other medical
indications, protect against cancer?
Asad Umar, Ph.D., chief, Gastrointestinal & Other Cancers Research Group, NCI/
Brandy Heckman, Ph.D, program director, Breast and Gynecologic Cancer Research
How do we improve tumor detection and characterization with diagnostic
Lalitha Shankar, M.D., Ph.D., branch chief, Clinical Trials Branch, Cancer Imaging
Can we develop preclinical models that better predict the efficacy of new
drugs and drug combinations?
Glen Merlino, Ph.D., chief, Laboratory of Cancer Biology and Genetics, NCI
When: Monday, December 10, 2012: 2:00- 4:00 p.m. (EST)
Where: National Institutes of Health: Building 31, Room 11A01
How: To view an archived webcast version of the seminar online please go to: http://1.usa.gov/NCIPQSWS.